Serum selenium concentrations and hypertension in the US Population.
Serum selenium concentrations and hypertension in the US Population.
复制标题
DOI:
10.1161/circoutcomes.108.831552
复制
发表时间:
2009-07
期刊:
影响因子:
--
通讯作者:
Guallar E
中科院分区:
文献类型:
--
作者:
Laclaustra M;Navas-Acien A;Stranges S;Ordovas JM;Guallar E
Selenium is an antioxidant micronutrient with potential interest for cardiovascular disease prevention. Few studies have evaluated the association between selenium and hypertension, with inconsistent findings. We explored the relationship of serum selenium concentrations with blood pressure and hypertension in a representative sample of the US population. Cross-sectional analysis of 2,638 adults ≥40 year old who participated in the National Health and Nutrition Examination Survey (NHANES) 2003–2004. Serum selenium was measured by inductively coupled plasma-dynamic reaction cell-mass spectrometry. Hypertension was defined as blood pressure ≥140/90 mmHg or current use of antihypertensive medication. Mean serum selenium was 137.1 µg/L. The multivariable adjusted differences (95% confidence interval) in blood pressure levels comparing the highest (≥150 µg/L) to the lowest (<122 µg/L) quintile of serum selenium were 4.3 (1.3, 7.4), 1.6 (−0.5, 3.7) and 2.8 (0.8, 4.7) mmHg for systolic, diastolic, and pulse pressure, respectively. The corresponding odds ratio (95% CI) for hypertension was 1.73 (1.18, 2.53). In spline regression models, blood pressure levels and the prevalence of hypertension increased with increasing selenium concentrations up to 160 µg/L. High serum selenium concentrations were associated with higher prevalence of hypertension. These findings call for a thorough evaluation of the risks and benefits associated with high selenium status in the US.